000 01251 a2200361 4500
005 20250517223101.0
264 0 _c20180906
008 201809s 0 0 ger d
022 _a0040-5930
024 7 _a10.1024/0040-5930/a000961
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEich, Philipp E
245 0 0 _a[Pharmacotherapy of schizophrenia spectrum disorders: State of the Art].
_h[electronic resource]
260 _bTherapeutische Umschau. Revue therapeutique
_cJun 2018
300 _a9-17 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntipsychotic Agents
_xtherapeutic use
650 0 4 _aCombined Modality Therapy
650 0 4 _aDrug Monitoring
650 0 4 _aDrug Therapy, Combination
650 0 4 _aEarly Diagnosis
650 0 4 _aEarly Medical Intervention
650 0 4 _aHumans
650 0 4 _aLong-Term Care
650 0 4 _aProdromal Symptoms
650 0 4 _aPrognosis
650 0 4 _aRecurrence
650 0 4 _aSchizophrenia
_xdiagnosis
650 0 4 _aSchizophrenic Psychology
700 1 _aNick, Beat
773 0 _tTherapeutische Umschau. Revue therapeutique
_gvol. 75
_gno. 1
_gp. 9-17
856 4 0 _uhttps://doi.org/10.1024/0040-5930/a000961
_zAvailable from publisher's website
999 _c28537382
_d28537382